Homemarket Newsstocks News

    Cipla shares tumble as USFDA flags Goa facility after inspection

    Cipla shares tumble as USFDA flags Goa facility after inspection

    Cipla shares tumble as USFDA flags Goa facility after inspection
    Profile image

    By CNBC-TV18  IST (Updated)

    Mini

    Cipla shares fell over 2 percent in the early trade on Thursday after the United States Food and Drug Administration (USFDA) classified the inspection conducted at company’s Goa manufacturing facility as official action indicated (OAI).

    Cipla shares fell over 2 percent in the early trade on Thursday after the United States Food and Drug Administration (USFDA) classified the inspection conducted at company’s Goa manufacturing facility as official action indicated (OAI).
    The scrip touched an intraday low of Rs 460 after falling 2.49 percent on the BSE.
    At 9:45 am, shares of Cipla traded 0.72 percent lower at Rs 468.35 on the BSE.
    The inspection at the facility was conducted between September 16-27, 2019.
    Speaking to CNBC-TV18, Kedar Upadhye, global CFO, Cipla said that the developments will not have any material impact on the company's US business at this stage.
    The exposure of single source products from Goa plant is less than 2.5 percent of total sales, he added saying that all other facilities are compliant.
    The company has been active in a de-risking program in the past one year and has drug filings from multiple plants.
     
    Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
    arrow down

      Most Read

      Market Movers

      View All
      CompanyPriceChng%Chng